JP2024501257A5 - - Google Patents
Info
- Publication number
- JP2024501257A5 JP2024501257A5 JP2023538074A JP2023538074A JP2024501257A5 JP 2024501257 A5 JP2024501257 A5 JP 2024501257A5 JP 2023538074 A JP2023538074 A JP 2023538074A JP 2023538074 A JP2023538074 A JP 2023538074A JP 2024501257 A5 JP2024501257 A5 JP 2024501257A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- co2h
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063130023P | 2020-12-23 | 2020-12-23 | |
| US63/130,023 | 2020-12-23 | ||
| PCT/US2021/064881 WO2022140555A1 (en) | 2020-12-23 | 2021-12-22 | Carboxylic acid containing indanyl compounds for the treatment of neurodegenerative diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024501257A JP2024501257A (ja) | 2024-01-11 |
| JP2024501257A5 true JP2024501257A5 (cg-RX-API-DMAC7.html) | 2024-12-23 |
| JP7851934B2 JP7851934B2 (ja) | 2026-04-27 |
Family
ID=82160119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023538074A Active JP7851934B2 (ja) | 2020-12-23 | 2021-12-22 | 神経変性疾患の治療のための、インダニルを含むカルボン酸化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12624003B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4267117B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7851934B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230124992A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116685313A (cg-RX-API-DMAC7.html) |
| ES (1) | ES3073110T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022140555A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240021883A (ko) | 2021-06-16 | 2024-02-19 | 셀진 코포레이션 | 신경변성 질환의 치료를 위한 카르복실산 기를 포함하는 아제티디닐 화합물 |
| WO2023107563A1 (en) * | 2021-12-07 | 2023-06-15 | Celgene Corporation | Carboxylic acid containing indanyl compounds for the treatment of neurodegenerative diseases |
| CN120019042A (zh) * | 2022-07-18 | 2025-05-16 | 细胞基因公司 | 用于治疗神经退行性疾病的化合物 |
| US20260209203A1 (en) * | 2022-12-16 | 2026-07-23 | Celgene Corporation | Heterocyclic Compounds as Modulators of S1P5 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE496024T1 (de) * | 2002-12-20 | 2011-02-15 | Merck Sharp & Dohme | 1-(amino)indane als edg-rezeptoragonisten |
| US7632854B2 (en) | 2004-11-17 | 2009-12-15 | Pfizer Italia S.R.L. | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| US8217027B2 (en) * | 2006-12-21 | 2012-07-10 | Abbott Laboratories | Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| US8637528B2 (en) * | 2007-03-27 | 2014-01-28 | Omeros Corporation | Use of PDE7 inhibitors for the treatment of movement disorders |
| US8592426B2 (en) | 2011-01-24 | 2013-11-26 | Hoffmann—La Roche Inc. | Aryl-benzocycloalkyl amide derivatives |
| BR112016022575A2 (pt) | 2014-03-28 | 2017-08-15 | Azevan Pharmaceuticals Inc | Composições e métodos para o tratamento de doenças neurodegenerativas |
| EP3228615B1 (en) | 2014-12-04 | 2021-01-20 | ONO Pharmaceutical Co., Ltd. | Dihydronaphthalene derivatives useful in the treatment of s1p5-mediated diseases |
| US10280159B2 (en) | 2015-12-22 | 2019-05-07 | AbbVie Deutschland GmbH & Co. KG | Fused (hetero)cyclic compounds as S1P modulators |
-
2021
- 2021-12-22 CN CN202180087384.3A patent/CN116685313A/zh active Pending
- 2021-12-22 KR KR1020237024762A patent/KR20230124992A/ko active Pending
- 2021-12-22 EP EP21912148.0A patent/EP4267117B1/en active Active
- 2021-12-22 US US18/267,551 patent/US12624003B2/en active Active
- 2021-12-22 WO PCT/US2021/064881 patent/WO2022140555A1/en not_active Ceased
- 2021-12-22 JP JP2023538074A patent/JP7851934B2/ja active Active
- 2021-12-22 ES ES21912148T patent/ES3073110T3/es active Active